Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors

European Journal of Pharmacology

Volumn 587, Issue 1-3, 2008, Pages 231-236

  Frascarelli, Sabina ^a   Ghelardoni, Sandra ^a   Chiellini, Grazia ^a   Vargiu, Romina ^b   Ronca Testoni, Simonetta ^a   Scanlan, Thomas S ^c   Grandy, David K ^c   Zucchi, Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Phenylethylamine; G protein coupled receptor; Myocardial function; Octopamine; p Tyramine; Signal transduction; Thyronamine; Tryptamine

Indexed keywords

3 IODOTHYRONAMINE; AMINE; GENISTEIN; IODINE 125; OCTOPAMINE; PHENETHYLAMINE; RADIOLIGAND; THYRONAMINE; TRITIUM; TRYPTAMINE; TYRAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEART HEMODYNAMICS; HEART OUTPUT; IC 50; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BIOGENIC AMINES; BLOOD PRESSURE; CARDIAC OUTPUT; CORONARY CIRCULATION; HEART; HEART RATE; MALE; MYOCARDIUM; PAPILLARY MUSCLES; PROPRANOLOL; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; RECEPTORS, BIOGENIC AMINE; RECEPTORS, G-PROTEIN-COUPLED; SYMPATHOMIMETICS; THYRONINES; TYRAMINE;

EID: 44149123755     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.03.055     Document Type: Article

References (21)

1. Berry M.D. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J. Neurochem. 90 (2004) 257-271
2. 2+ signaling: direct interactions with fura-2. Eur. J. Pharmacol. 389 (2000) 35-40
3. Black J.W., Jenkinson D.H., and Kenaki T.P. Antagonism of an indirectly acting agonist: block by propranolol and sotalol of the action of p-tyramine on rat heart. Eur. J. Pharmacol. 11 (1980) 1-10
4. Borowsky B., Adham N., Jones K.A., Raddaz R., Artymyshyn R., Ogozalek K.L., Durkin M.M., Lakhlani P.P., Bonini J.A., Pathirana S., Boyle N., Pu X., Kouranova E., Lichtblau H., Ochoa F.Y., Branchek T.A., and Gerald C. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8966-8971
5. Brasch H., Iven H.B., and Zetler G. Effects of simple indoles, noradrenaline, nicotine, and p-tyramine on action potential and contractility of the isolated guinea-pig papillary muscle. Naunyn Schmiedeberg's Arch. Pharmacol. 6 (1977) 259-265
6. Bunzow J.R., Sonders M.S., Arttamangkul S., Harrison L.M., Zhang G.E., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., Kennedy J.L., Olson S.B., Magenis E., Amara S.G., and Grandy D.K. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of the rat trace amine receptor. Mol. Pharmacol. 60 (2001) 1181-1188
7. Burchett S.A., and Hicks T.P. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog. Neurobiol. 79 (2006) 223-246
8. Chakrabarti S.K. Styrene and styrene oxide affect the transport of dopamine in purified rat striatal synaptic vesicles. Biochem. Biophys. Res. Commun. 255 (1999) 70-74
9. Chiba S. Pharmacologic analysis of positive chronotropic and inotropic responses to octopamine. Tohoku J. Exp. Med. 118 (1976) 247-253
10. Chiellini G., Frascarelli S., Ghelardoni S., Carnicelli V., Tobias S.C., DeBarber A., Brogioni S., Ronca-Testoni S., Cerbai E., Grandy D.K., Scanlan T.S., and Zucchi R. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J. 21 (2007) 1597-1608
11. Graefe K.H., Bossle F., Woelfel R., Burger A., Souladaki M., Bier D., Dutschka K., Farahati J., and Boenisch H. Sympathomimetic effects of MIBG: comparison with p-tyramine. J. Nucl. Med. 40 (1999) 1342-1351
12. Grandy D.K. Trace amine-associated receptor 1 - family archetype or iconoclast?. Pharmacol. Ther. 116 (2007) 355-390
13. Hart M.E., Suchland K.L., Miyakawa M., Bunzow J.R., Grandy D.K., and Scanlan T.S. Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. J. Med. Chem. 49 (2006) 1101-1112
14. Kopin I.J. False adrenergic transmitters. Annu. Rev. Pharmacol. 8 (1968) 377-394
15. Kopin I.J., Fischer J.E., Musacchio J., and Horst W.D. Evidence for a false neurochemical transmitter as a mechanism for the hypotensive effect of monoamine oxidase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 52 (1964) 716-721
16. Lindemann L., Ebeling M., Kratochwil N.A., Bunzow J.R., Grandy D.K., and Hoener M.C. Trace amine associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85 (2005) 372-385
17. + current in rat osteoclasts. Jpn. J. Physiol. 51 (2001) 502-509
18. Pesce G., and Adler-Graschinsky E. Comparison of the effects of beta-phenylethylamine and d-amphetamine on rat isolated atria. J. Pharmacol. Exp. Ther. 227 (1983) 205-214
19. Scanlan T.S., Suchland K.L., Hart M.E., Chiellini G., Huang Y., Kruzich P.J., Frascarelli S., Crossley D.A., Bunzow J.R., Ronca-Testoni S., Lin E.T., Hatton D., Zucchi R., and Grandy D.K. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat. Med. 10 (2004) 638-642
20. 3H]-p-tyramine in the central nervous system. Br. J. Pharmacol. 89 (1986) 15-25
21. Zucchi R., Chiellini G., Scanlan T.S., and Grandy D.K. Trace amine-associated receptors and their ligands. Br. J. Pharmacol. 149 (2006) 967-978